Pharmaceutical sector is, by far, one of the biggest wealth creators in 2020, it was the first sector to bounce back after the lows in March and the run is more or less continued. What after the mammoth gains that pharma index and largecap pharma stocks have seen? Prakash Agarwal, Pharma Analyst at Axis Capital, who tracks this space, discussed this on CNBC-TV18.
The big rerating has happened in pharmaceutical sector. We remain positive on the sector but we also are selective on stocks, he said.
We are looking at Cadila Healthcare, Divi’s Laboratories, Biocon as our top picks followed by Dr Reddy’s Laboratories (DRL) and Cipla, he added.
We have a reduced rating on Sun Pharmaceuticals and Syngene, Agarwal mentioned.
Watch video for more